Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study-Reference-Cited by-同舟云学术

Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study

Published:2021-10-13 Issue:23 Volume:10 Page:8421-8431
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Qi Weili¹^ORCID,Shen Junyi¹,Dai Junlong¹,Wu Youwei¹,Zhang Yu²,Leng Shusheng³,Gao Fengwei⁴,Ran Shun⁵,Peng Wei¹,Zhang Xiaoyun¹,Wen Tianfu¹^ORCID,Li Chuan¹

Affiliation:

1. Department of Liver Surgery and Liver Transplantation Center West China Hospital of Sichuan University Chengdu Sichuan China

2. Organ Transplantation Center Sichuan Provincial People’s Hospital Chengdu Sichuan China

3. Department of Hepatopancreatobiliary Surgery Affiliated Hospital of Chengdu University Chengdu Sichuan China

4. HBPS Diseases Center for Diagnosis and Treatment of Leshan CityPeople’s Hospital of Leshan Leshan Sichuan China

5. Department of Hepatopancreatobiliary Surgery Affiliated Cancer Hospital of Guizhou Medical University Guiyang, Guizhou China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4348

Reference35 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. Randomized controlled trial of screening for hepatocellular carcinoma

4. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights

5. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis;Frontiers in Pharmacology;2024-08-22

2. A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection;Frontiers in Pharmacology;2024-07-29

3. Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma;Journal of Surgical Research;2024-03

4. Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis;Hepatology International;2024-01-02

5. Enhanced prognosis of HCC patients undergoing radical treatments with tenofovir versus entecavir: A meta-analysis based on propensity score matching studies;Asian Journal of Surgery;2024-01